Financing ·
Harvard Apparatus Regenerative Technology entered into two related-party bridge notes with Chairman and CEO Junli He…
HRGNHarvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology entered into two related-party bridge notes with Chairman and CEO Junli He for a total of $400,000 ($200,000 each). The May Bridge Note was executed on May 8, 2026, and the July Bridge Note on July 16, 2026. Both notes accrue interest at an annual fixed rate of 8% and mature on the earlier of a qualifying capital raise with gross proceeds of at least $5 million or their respective one-year anniversaries. The outstanding balances may be converted into equity at the purchaser's price if the company raises at least $200,000 in new equity before maturity. These transactions were approved by disinterested board members. Harvard Apparatus Regenerative Technology operates in the biotechnology and medical device industry, focusing on regenerative medicine technologies.